Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes: Prescription According to Reimbursement Constraints and Guideline Recommendations in Catalonia

To assess the clinical characteristics, the prescription pattern of GLP-1 receptor agonists (GLP-1RA) users, and HbA1c and weight change, we retrospectively assessed patients with type 2 diabetes by initiating GLP-1RA as an add-on to the standard of care in Catalonia. The mean change from the baseli...

Descripción completa

Detalles Bibliográficos
Autores principales: Franch-Nadal, Josep, Mata-Cases, Manel, Ortega, Emilio, Real, Jordi, Gratacòs, Mònica, Vlacho, Bogdan, Vallés, Joan Antoni, Mauricio, Dídac
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780172/
https://www.ncbi.nlm.nih.gov/pubmed/31491916
http://dx.doi.org/10.3390/jcm8091389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780172/
https://www.ncbi.nlm.nih.gov/pubmed/31491916
http://dx.doi.org/10.3390/jcm8091389

Ejemplares similares